Literature DB >> 1454819

Molecular characterization of NAD:arginine ADP-ribosyltransferase from rabbit skeletal muscle.

A Zolkiewska1, M S Nightingale, J Moss.   

Abstract

Mono-ADP-ribosylation is a reversible modification of proteins, with NAD:arginine ADP-ribosyltransferases (EC 2.4.2.31) and ADP-ribosylarginine hydrolases (EC 3.2.2.19) catalyzing the opposing reactions in an ADP-ribosylation cycle. A membrane-associated arginine-specific (mono)-ADP-ribosyltransferase was purified 215,000-fold from rabbit skeletal muscle. On the basis of the amino acid sequences of HPLC-purified tryptic peptides, degenerate oligonucleotide primers were synthesized and used in a polymerase chain reaction (PCR)-based procedure to generate cDNA. A specific probe, based on PCR-generated sequence, was used to screen a rabbit skeletal muscle cDNA library. A composite cDNA sequence, obtained from library screening and rapid amplification of the 5' end of the cDNA, contained a 981-base-pair open reading frame, encoding a 36,134-Da protein. The deduced amino acid sequence contained the sequences of the tryptic peptides, hydrophobic amino and carboxyl termini, and two potential sites for N-linked glycosylation. Escherichia coli cells transformed with an expression vector containing transferase-specific sequence expressed ADP-ribosyltransferase activity. A transferase-specific oligonucleotide probe recognized a 4-kilobase mRNA expressed primarily in rabbit skeletal and cardiac muscle. There was no extended similarity in deduced amino acid sequences of the muscle transferase and several bacterial ADP-ribosylating toxins. The hydrophobic amino and carboxyl termini may represent a signal peptide and a site for a glycosyl-phosphatidylinositol anchor, respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454819      PMCID: PMC50548          DOI: 10.1073/pnas.89.23.11352

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Purification and partial characterization of arginine-specific ADP-ribosyltransferase from skeletal muscle microsomal membranes.

Authors:  J E Peterson; J S Larew; D J Graves
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

2.  Arginine-specific ADP-ribosyltransferase from rabbit skeletal muscle sarcoplasmic reticulum is solubilized as the active form with trypsin: partial purification and characterization.

Authors:  M Taniguchi; Y Tanigawa; M Tsuchiya; K Mishima; S Obara; K Yamada; M Shimoyama
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

3.  Improvement and simplification of low-background silver staining of proteins by using sodium dithionite.

Authors:  T Rabilloud; G Carpentier; P Tarroux
Journal:  Electrophoresis       Date:  1988-06       Impact factor: 3.535

4.  Diphtheria toxin. Effect of substituting aspartic acid for glutamic acid 148 on ADP-ribosyltransferase activity.

Authors:  R K Tweten; J T Barbieri; R J Collier
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

5.  Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development.

Authors:  J J Mekalanos; D J Swartz; G D Pearson; N Harford; F Groyne; M de Wilde
Journal:  Nature       Date:  1983 Dec 8-14       Impact factor: 49.962

6.  Evidence for the endogenous GTP-dependent ADP-ribosylation of the alpha-subunit of the stimulatory guanyl-nucleotide-binding protein concomitant with an increase in basal adenylyl cyclase activity in chicken spleen cell membrane.

Authors:  S Obara; K Yamada; Y Yoshimura; M Shimoyama
Journal:  Eur J Biochem       Date:  1991-08-15

7.  Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor.

Authors:  J Moss; M Vaughan
Journal:  J Biol Chem       Date:  1977-04-10       Impact factor: 5.157

8.  Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli.

Authors:  T K Sixma; S E Pronk; K H Kalk; E S Wartna; B A van Zanten; B Witholt; W G Hol
Journal:  Nature       Date:  1991-05-30       Impact factor: 49.962

9.  Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.

Authors:  V S Allured; R J Collier; S F Carroll; D B McKay
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 12.779

10.  Active site of Pseudomonas aeruginosa exotoxin A. Glutamic acid 553 is photolabeled by NAD and shows functional homology with glutamic acid 148 of diphtheria toxin.

Authors:  S F Carroll; R J Collier
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.486

View more
  31 in total

1.  Regulation of glutamate dehydrogenase by reversible ADP-ribosylation in mitochondria.

Authors:  A Herrero-Yraola; S M Bakhit; P Franke; C Weise; M Schweiger; D Jorcke; M Ziegler
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  Mono ADP-ribosylation inhibitors prevent inflammatory cytokine release in alveolar epithelial cells.

Authors:  Mariangela Del Vecchio; Enrico Balducci
Journal:  Mol Cell Biochem       Date:  2007-12-09       Impact factor: 3.396

3.  ART1 promotes starvation-induced autophagy: a possible protective role in the development of colon carcinoma.

Authors:  Yi Tang; Ming Li; Ya-Lan Wang; Michael D Threadgill; Ming Xiao; Chun-Feng Mou; Guang-Lin Song; Jing Kuang; Xi Yang; Li Yang; Xing-Jie Gao; Ya-Ping Wang; Yun-Peng Meng
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

4.  Critical role for NAD glycohydrolase in regulation of erythropoiesis by hematopoietic stem cells through control of intracellular NAD content.

Authors:  Tae-Sik Nam; Kwang-Hyun Park; Asif Iqbal Shawl; Byung-Ju Kim; Myung-Kwan Han; Youngho Kim; Joel Moss; Uh-Hyun Kim
Journal:  J Biol Chem       Date:  2014-04-23       Impact factor: 5.157

5.  Cell-surface ADP-ribosylation of fibroblast growth factor-2 by an arginine-specific ADP-ribosyltransferase.

Authors:  E M Jones; A Baird
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

Review 6.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

7.  Reduction by inhibitors of mono(ADP-ribosyl)transferase of chemotaxis in human neutrophil leucocytes by inhibition of the assembly of filamentous actin.

Authors:  J R Allport; L E Donnelly; B P Hayes; S Murray; N B Rendell; K P Ray; J MacDermot
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

8.  Molecular characterization and expression of the gene for mouse NAD+:arginine ecto-mono(ADP-ribosyl)transferase, Art1.

Authors:  R Braren; G Glowacki; M Nissen; F Haag; F Koch-Nolte
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

Review 9.  Vertebrate mono-ADP-ribosyltransferases.

Authors:  A Zolkiewska; I J Okazaki; J Moss
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

10.  Characterization of botulinum C3-catalyzed ADP-ribosylation of rho proteins and identification of mammalian C3-like ADP-ribosyltransferase.

Authors:  T Maehama; N Sekine; H Nishina; K Takahashi; T Katada
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.